Business Wire

Thales and L&T Technology Services Expand Collaboration to Provide Innovative Business Models to Customers

21.8.2024 16:00:00 EEST | Business Wire | Press release

Share

Thales, a leading global technology and security provider, has announced a new contract with engineering and R&D firm L&T Technology Services Limited (LTTS). This partnership will bring Thales’s software monetization platform, Thales Sentinel, to LTTS’ customer base, especially in the Hi-tech, Sustainability and Mobility segments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240821145825/en/

© L&T Technology Services Limited

With over two decades of experience in deploying intelligent digital solutions, LTTS leads in optimizing enterprise operations and pioneering platforms in AI, Mobility, Sustainability, and Hi-Tech. LTTS’ advanced AI offerings in next-gen mobility and smart networks are pivotal in building robust digital infrastructures, enhancing safety, efficiency, and sustainability. Now with the Thales Sentinel software licensing and entitlement platform, LTTS will enable its customers to monetize its software solutions by harnessing recurring revenue business models including agile subscriptions and flexible usage-based pricing models.

Damien Bullot, Vice President, Software Monetization Solutions at Thales: “This partnership builds on Thales’s long standing relationship with LTTS, helping their customers unlock the true value and potential of their software products through flexible pricing and subscription models, better compliance, and automated delivery and activation. We look forward to our continued collaboration to ensure their industry-leading AI offers are properly protected and monetized for maximum ROI.”

Under the new contract, LTTS will resell the Thales Sentinel platform to its customer base and group affiliates globally across diverse sectors, including transportation, medical, hi-tech, telecom, and financial services.

Alind Saxena, Executive Director & President, Mobility & Tech at L&T Technology Services: “Our partnership with Thales underscores our commitment to drive innovation and superior solutions across mobility, sustainability, and hi-tech, leveraging their Sentinel platform. Our proficiency in creating cutting-edge digital solutions and our deep understanding of AI will form the backbone of a robust digital infrastructure. We anticipate contributing to a cohesive digital thread throughout the value chain, accelerating market entry, reducing cycle time along with product development costs, and aiding our customers in their journey towards sustainability through improved software monetization potential."

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity.

It develops products and solutions that help make the world safer, greener and more inclusive.

The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.

Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240821145825/en/

Contacts

PRESS
Thales, Media Relations
Security & Cybersecurity
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com

PLEASE VISIT
Thales Group -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.thalesgrou
p.com%2Fen&esheet=54111798&newsitemid=20240821145825&lan=en-US&anchor=Thales+Gro
up&index=3&md5=b7bfe84f488f2822557dcf69d9908739
Cloud Protection & Licensing Solutions | Thales Group -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fcpl.thalesgrou
p.com%2F&esheet=54111798&newsitemid=20240821145825&lan=en-US&anchor=Cloud+Protec
tion+%26amp%3B+Licensing+Solutions+%7C+Thales+Group&index=4&md5=44b930513072a267
dd250f72eb8abd6f
Cybersecurity Solutions | Thales Group -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.thalesgrou
p.com%2Fen%2Fmarkets%2Ftransverse-markets%2Fcybersecurity-solutions&esheet=54111
798&newsitemid=20240821145825&lan=en-US&anchor=Cybersecurity+Solutions+%7C+Thale
s+Group&index=5&md5=529aa6b3a29cf47d5193347903493d24

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye